Longitudinal assessment of BMI in relation to ADT use among early stage prostate cancer survivors.

Journal of cancer survivorship : research and practice

Volumn 3, Issue 4, 2009, Pages 233-240

  Beehler, Gregory P ^a   Wade, Michael ^a   Kim, Borah ^a   Steinbrenner, Lynn ^a   Wray, Laura O ^a  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN;

AGED; ARTICLE; BODY MASS; HUMAN; LONGITUDINAL STUDY; MALE; PATHOLOGY; PROGNOSIS; PROSTATE TUMOR; SURVIVOR; TREATMENT OUTCOME;

AGED; ANDROGEN ANTAGONISTS; BODY MASS INDEX; HUMANS; LONGITUDINAL STUDIES; MALE; PROGNOSIS; PROSTATIC NEOPLASMS; SURVIVORS; TREATMENT OUTCOME;

EID: 77949884302     PISSN: None     EISSN: 19322267     Source Type: Journal    
DOI: 10.1007/s11764-009-0099-9     Document Type: Article

References (0)